Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules

Baris, Akinci; Tevfik, Demir; Abdurrahman, Comlekci; Serkan, Yener; Mehmet Ali, Ozcan; Oguzhan, Karaoglu; Faize, Yuksel; Mustafa, Secil; Sena, Yesil

Baris, Akinci; Tevfik, Demir; Abdurrahman, Comlekci; Serkan, Yener; Mehmet Ali, Ozcan; Oguzhan, Karaoglu; Faize, Yuksel; Mustafa, Secil; Sena, Yesil.

Medical Principles and Practice. 2011; 20 (1): 23-28

in En | IMEMR | ID: emr-110992

Responsible library: EMRO

Subject(s)

Humans; Female; Thyroxine; Thrombin; Fibrinolysis; Carboxypeptidase B2; Thyroid Nodule; Prospective Studies; Plasminogen Activator Inhibitor 1; Hyperthyroidism

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Thyroxine / Thrombin / Prospective Studies / Thyroid Nodule / Plasminogen Activator Inhibitor 1 / Carboxypeptidase B2 / Fibrinolysis / Hyperthyroidism Limits: Female / Humans Language: En Journal: Med. Princ. Pract. Year: 2011

Search on Google

Add to My VHL

XML